APA (7th ed.) Citation

Nasirzadeh, A., Jahanshahi, R., Ghajarzadeh, M., Mohammadi, A., Sahraian, M. A., & Moghadasi, A. N. (2023). The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) who were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis. International Journal of Preventive Medicine, 14(1), 1. https://doi.org/10.4103/ijpvm.ijpvm_77_22

Chicago Style (17th ed.) Citation

Nasirzadeh, Amirreza, Reza Jahanshahi, Mahsa Ghajarzadeh, Aida Mohammadi, Mohammad Ali Sahraian, and Abdorreza Naser Moghadasi. "The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) Who Were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis." International Journal of Preventive Medicine 14, no. 1 (2023): 1. https://doi.org/10.4103/ijpvm.ijpvm_77_22.

MLA (9th ed.) Citation

Nasirzadeh, Amirreza, et al. "The Prevalence of Cancer in Patients with Multiple Sclerosis (MS) Who Were Under Treatment with Natalizumab (Tysabri): A Systematic Review and Meta-Analysis." International Journal of Preventive Medicine, vol. 14, no. 1, 2023, p. 1, https://doi.org/10.4103/ijpvm.ijpvm_77_22.